Cleared Traditional

K113264 - ELECTRO SENSOR COMPLEX SOFTWARE (ES COMPLEX SOFTWARE)

K113264 is an FDA 510(k) clearance for ELECTRO SENSOR COMPLEX SOFTWARE (ES COM..., manufactured by Ld Technology, LLC. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 119-day FDA review.

K113264 · Ld Technology, LLC · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2012
Decision
119d
Days
Class 2
Risk

K113264 is an FDA 510(k) clearance for the ELECTRO SENSOR COMPLEX SOFTWARE (ES COMPLEX SOFTWARE). Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Ld Technology, LLC (Miami, US). The FDA issued a Cleared decision on March 2, 2012 after a review of 119 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Ld Technology, LLC devices

FDA 510(k) Submission Details - K113264

510(k) Number K113264 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 04, 2011
Decision Date March 02, 2012
Days to Decision 119 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
6d faster than avg
Panel avg: 125d · This submission: 119d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 844
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K113264.
SOLOHEALTH STATION
K113402 · Solohealth, Inc. · May 2012
TL-200 T-LINE NON-INVASIVE BLOOD PRESSURE MONITORING SYSTEM
K121141 · Tensys Medical Systems, Inc. · May 2012
FULL AUTOMATIC (NIBP) BLOOD PRESSURE MONITOR (MODEL HL168KF)
K113239 · Health & Life Co., Ltd. · Mar 2012
FULL AUTOMATIC (NIBP) BLOOD PRESSUE MONITOR
K113238 · Health & Life Co., Ltd. · Mar 2012
BLOOD PRESSURE MONITOR
K112690 · Nihon Seimitsu Sokki Co., Ltd. · Feb 2012
BLOOD PRESSURE MONITOR
K112691 · Nihon Seimitsu Sokki Co., Ltd. · Feb 2012